Alnylam Pharmaceuticals
ALNY
#443
Rank
HK$407.12 B
Marketcap
HK$3,082
Share price
1.00%
Change (1 day)
66.66%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company